CRYO-CELL International, Inc. (CCEL):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:CRYO-CELL International, Inc. (CCEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81683FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Cryo-Cell International, Inc. (Cryo-Cell) is a biotechnology company. The company provides collection and preservation of umbilical cord blood stem cells for family use. It offers services, such as cord blood banking, cord tissue banking, cord blood and tissue pricing, menstrual blood banking, menstrual pricing, and online payment. Cryo-Cell offers menstrual stem cell service to capture self-renewing stem cells, and processes and cryopreserves them for cellular therapies and potential treatment of various life threatening diseases, such as to stroke, heart disease, diabetes, neurodegenerative diseases, and ischemic wounds. The company partners with Stanford University, University of South Florida, Florida Blood Services, and others. Cryo-Cell is headquartered in Oldsmar, Florida, the US.

CRYO-CELL International, Inc. Key Recent Developments

Oct 15, 2013: Cryo-Cell Reports Third Quarter 2013 Results
Apr 05, 2013: Cryo-Cell Reports Revenue Of $4.6m In Q1 Fiscal 2013
Mar 15, 2013: Cryo-Cell Affiliate Earns Patent For Processing Umbilical Cord Blood For Therapeutic Use
Feb 28, 2013: Cryo-Cell Reports Revenue Of $18m In Fiscal 2012
Jan 08, 2013: Cryo-Cell’s Phase II Study Shows Promising Results Using Cord Blood Stem Cells To Treat Cerebral Palsy

This comprehensive SWOT profile of CRYO-CELL International, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CRYO-CELL International, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CRYO-CELL International, Inc. – Key Information
CRYO-CELL International, Inc. – Overview
CRYO-CELL International, Inc. – Key Employees
CRYO-CELL International, Inc. – Key Employee Biographies
CRYO-CELL International, Inc. – Key Operational Heads
CRYO-CELL International, Inc. – Major Products and Services
CRYO-CELL International, Inc. – History
CRYO-CELL International, Inc. – Company Statement
CRYO-CELL International, Inc. – Locations And Subsidiaries
CRYO-CELL International, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CRYO-CELL International, Inc. – Business Description
CRYO-CELL International, Inc. – Corporate Strategy
CRYO-CELL International, Inc. – SWOT Analysis
SWOT Analysis – Overview
CRYO-CELL International, Inc. – Strengths
CRYO-CELL International, Inc. – Weaknesses
CRYO-CELL International, Inc. – Opportunities
CRYO-CELL International, Inc. – Threats
CRYO-CELL International, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

CRYO-CELL International, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CRYO-CELL International, Inc., Key Information
CRYO-CELL International, Inc., Key Ratios
CRYO-CELL International, Inc., Share Data
CRYO-CELL International, Inc., Major Products and Services
CRYO-CELL International, Inc., History
CRYO-CELL International, Inc., Key Employees
CRYO-CELL International, Inc., Key Employee Biographies
CRYO-CELL International, Inc., Key Operational Heads
CRYO-CELL International, Inc., Other Locations
CRYO-CELL International, Inc., Subsidiaries
CRYO-CELL International, Inc., Key Manufacturing facilities
CRYO-CELL International, Inc., Key Competitors
CRYO-CELL International, Inc., SWOT Analysis
CRYO-CELL International, Inc., Ratios based on current share price
CRYO-CELL International, Inc., Annual Ratios
CRYO-CELL International, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

CRYO-CELL International, Inc., Performance Chart
CRYO-CELL International, Inc., Ratio Charts

★海外企業調査レポート[CRYO-CELL International, Inc. (CCEL):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Equity Residential:企業の戦略・SWOT・財務分析
    SummaryEquity Residential - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Otto Bock HealthCare GmbH:企業のM&A・提携動向(医療機器分野)
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • Cardo AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cardo AB Mergers and Acquisitio …
  • Grasim Industries Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Grasim Industries Limited Merge …
  • OncoMed Pharmaceuticals, Inc. (OMED):企業の財務及び戦略的SWOT分析
    Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company that discovers and develops novel medicines for improving cancer treatment. The company's clinical stage pipeline includes demcizumab, tarextumab, vantictumab, ipafricept, brontictuzumab and anti-DDL4/VEGF. It offers preclini …
  • Bank of India (BANKINDIA):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bank of India" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a s …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業財務及び戦略的SWOT分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • China Wire & Cable Co., Ltd. (1603):企業財務及び戦略的SWOT分析
    Summary China Wire & Cable Co., Ltd. (CWCO) is an electrical equipment company that develops and distributes cables, aluminum windows and curtain walls for the power industry. The company provides products such as aluminum wire for overhead transmission and distribution, all aluminum conductors, und …
  • Cynosure, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cynosure, Inc. Mergers and Acqu …
  • FleetPride, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' FleetPride, Inc. Mergers and Ac …
  • Arsenal Holdings PLC (AFC):企業の財務・戦略的SWOT分析
    Arsenal Holdings PLC (AFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Microvision, Inc. (MVIS):企業のM&A・提携動向(医療機器分野)
    Summary Microvision, Inc. (Microvision) is a medical device company that offers scanning technology solutions. The company offers PicoP scanning technology, an ultra-miniature laser projection and imaging solution based on the laser beam scanning methodology. It also offers consumer displays, vehicl …
  • Bentley Systems, Incorporatedの企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bentley Systems, Incorporated" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market …
  • McKesson Corp (MCK):企業財務及び戦略的SWOT分析
    McKesson Corp (MCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Premier Foods plc:企業の戦略・SWOT・財務分析
    Premier Foods plc - Strategy, SWOT and Corporate Finance Report Summary Premier Foods plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Assima PLC (ALSIM):企業の財務及び戦略的SWOT分析
    Summary Assima PLC (Assima) is an information technology company that develops and distributes cloning solutions. The company offers solutions used in training client that enables the creation of training content. Its products include training suite, multilingual suite, change management suite, STT …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Premier Inn:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Premier Inn Mergers and Acquisi …
  • Spirit AeroSystems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Spirit AeroSystems, Inc. Merger …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆